Evaluating The Frequency of Autoantibodies in Patients with Chronic Hepatitis B
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 1
Abstract
Objectives: The objective of this study is to evaluate the frequency of autoantibodies retrospectively in newly diagnosed chronic hepatitis B (CHB) patients. Materials and Methods: The study was retrospectively conducted in between Jan 2010 and August 2015 in a research and training hospital in İstanbul with 122 patients (ages of 17-80) consulted to Gastroenterology and Infection Diseases and diagnosed with CHB and 117 healthy control group. In both groups, positive and negative rates of anti-nuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-mitochondrial antibody (AMA) and anti-liver-kidney mitochondrial antibody (anti-LKM) were compared. Results: No AMA and LKM1 were observed in any patient or control groups. ANA result was positive in 9.8% of the patient group and 8.5% of the control group; and there was no statistically significant difference between them (p>0.05). ASMA result was positive in 5.7% of the patient group and 0.9% of the control group; and the difference between them was very close to significance but statistically not enough to be significant (p>0.05). Hepatosteatosis level of the patient group was significantly lower than the control group, statistically (p<0.05). Conclusion: In this study, it is concluded that the low frequency of autoantibody may depend on the fact that it was only examined in CHB patients who are not receiving any treatment. Examination of autoantibodies in newly diagnosed chronic hepatitis B patients before and after treatment may provide insight in terms of occuring autoimmune phenomena cases and extrahepatic findings.
Authors and Affiliations
Umut Aykanat, Fatma Ekşi Polat, Elif Yorulmaz, Hatice Yorulmaz, Münevver Gül Avşar, Mehmet Öncü, Ayşe Banu Esen, Ümit Seza Tetikkurt
Keywords
Related Articles
- EP ID EP684575
- DOI 10.4274/vhd.galenos.2020.2019.0035
- Views 126
- Downloads 0
Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response
Objectives: Although hepatocellular carcinoma (HCC) screening is accepted as standard care in patients with chronic hepatitis C (CHC) diagnosis, sustained viral response (SVR) has been obtained by treatment and it is not...
How Aware are We of the Immune Status of Hepatitis B and Hepatitis A in Chronic Hepatitis C Patients? A Multicenter Retrospective Study from Turkey
Objectives: Patients with chronic hepatitis C virus (HCV) infection and superinfection by hepatitis A or hepatitis B virus have higher morbidity and mortality when compared with those without HCV infection. The aim of th...
HBV Flare Under Tenofovir Treatment in Chronic Hepatitis B: Case Report
The purpose of chronic hepatitis B treatment is to stop the progression of the disease and prevent cirrhosis and liver cancer that may occur with the progression of the disease. In the current treatment, one of the nucle...
Hepatitis B Virus Infection: Knowledge and Awareness Among the Patients Admitted in a Tertiary Care Hospital in Bangladesh
Objectives: Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality in Bangladesh. An adequate level of knowledge and awareness among the general population is essential in prevention and control of...
Seroprevalence Investigation of Hepatitis B and Hepatitis B Core Antigen in Oncology Patients
Objectives: Hepatitis B virus (HBV) affects a significant part of society and is characterized by high mortality and morbidity. Hepatitis B affects approximately 350 million people worldwide, many of whom are chronic pat...